# name
Correction for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

# metadata.dc.description.abstract[].value
Medical sciences: correction for "Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing," by SoniaMelo, Alberto Villanueva, Catia Moutinho, Veronica Davalos, Riccardo Spizzo, Cristina Ivan, Simona Rossi, Fernando Setien, Oriol Casanovas, Laia Simo-Riudalbas, Javier Carmona, Jordi Carrere, August Vidal, Alvaro Aytes, Sara Puertas, Santiago Ropero, Raghu Kalluri, Carlo M. Croce, George A. Calin, and Manel Esteller, which appeared in issue 11, March 15, 2011, of Proc Natl Acad Sci USA (108:4394-4399; first published February 28, 2011; 10.1073/pnas.1014720108).

# metadata.dc.relation.ispartof[].value
Proceedings of the National Academy of Sciences of the United States of America - PNAS, 2017, vol. 114, num. 4, p. E650-E653

# metadata.dc.rights[].value
(c) Melo, Sónia Rita Cardoso, 1978- et al., 2017

# metadata.dc.source[].value
Articles publicats en revistes (Ciències Fisiològiques)

# metadata.dc.title[].value
Correction for Melo et al., Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing